GABITRIL

This brand name is authorized in Australia, Spain, France, Ireland, Lithuania, Poland, United Kingdom, United States

Active ingredients

The drug GABITRIL contains one active pharmaceutical ingredient (API):

1 Tiagabine hydrochloride monohydrate UNII DQH6T6D8OY - TIAGABINE HYDROCHLORIDE

Tiagabine is an anti-epileptic drug. Tiagabine is a potent and selective inhibitor of both neuronal and glial GABA uptake, which results in an increase in GABAergic medicated inhibition in the brain. Read about Tiagabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GABITRIL Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AG06	Tiagabine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8221Q, 8222R, 8223T
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61606, 61607, 61608
Country: FR	Base de données publique des médicaments	Identifier(s): 60058517, 61089729, 67859994
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39019, 39022, 41301
Country: IE	Health Products Regulatory Authority	Identifier(s): 58523, 58547, 58568
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004263, 1004264, 1007436, 1007437
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080823, 100080830, 100247298
Country: US	FDA, National Drug Code	Identifier(s): 63459-402, 63459-404, 63459-412, 63459-416